International Women's Day 2026

The article is closely linked to five key SDGs through its emphasis on gender equality and social inclusion (GESI) in agricultural water management. SDG 2 (Zero Hunger) highlights the critical role women play in food production and food security, underscoring the importance of ensuring equal access to water resources. SDG 5 (Gender Equality) focuses on reducing gender disparities, including unequal access to water resources and irrigation technologies. SDG 6 (Clean Water and Sanitation) calls for gender‑responsive approaches to water management. SDG 10 (Reduced Inequalities) stresses the need to ensure that marginalized groups, such as women and smallholder farmers, have equal rights to land and water resources. SDG 13 (Climate Action) advocates for integrating gender‑sensitive strategies into climate adaptation efforts related to agricultural water management. By aligning GESI principles with these SDGs, the article illustrates how inclusive approaches to agricultural water management can promote sustainable practices that alleviate poverty, strengthen food security, and support environmental sustainability, while also advancing social justice.

This chapter aligns with Goals 5, 8, and 10 by highlighting the significance of women’s entrepreneurship in promoting sustainable growth in Europe. The key argument is that achieving gender equality is essential for sustainable development, as outlined in the SDGs, which advocate for equal opportunities for all.

This chapter aligns well with the SDGs—primarily SDG 2 (Zero Hunger) and SDG 3 (Good Health and Well‑Being), while also supporting SDG 5 (Gender Equality) and SDG 10 (Reduced Inequalities). By using NFHS‑5 data on women 15–49, the study directly addresses indicator 2.2.2 (anemia prevalence) and provides NCD risk‑factor evidence relevant to SDG 3.4. The clear geographic and socioeconomic disparities you report underline the need for context‑specific, equity‑focused interventions and state‑level monitoring. To strengthen SDG relevance, map each outcome to specific SDG targets/indicators, use survey‑adjusted estimates, and propose measurable, region‑tailored actions for tracking progress.

This chapter aligns with SDG 3 – Good Health and Well‑Being and SDG 5 – Gender Equality by showing how nutraceuticals can enhance the prevention, treatment, and recurrence management of gynecologic cancers, thereby improving women’s health outcomes and addressing conditions that uniquely affect women.

This chapter advances SDG 3 – Good Health and Well‑Being and SDG 9 – Industry, Innovation and Infrastructure by demonstrating how artificial intelligence and machine learning can dramatically improve early diagnosis of cervical cancer, particularly in low‑ and middle‑income countries where mortality rates are highest. It also supports SDG 5 – Gender Equality, as cervical cancer predominantly affects women and improved screening technologies directly contribute to better health outcomes, reduced mortality, and greater equity in women’s healthcare access.

This chapter aligns with SDG Goal 5: Gender Equality and Goal 3: Good Health and Well-Being by emphasizing the importance of understanding sex and gender differences in Alzheimer’s disease risk, progression, and treatment, and highlighting the need for equitable research and interventions to improve health outcomes for women.

In this target trial emulation study, prophylactic antibiotic use did not raise the risk of hospital admission due to antibiotic-resistant or urinary tract infections, however it did increase the risk of antibiotic resistance in uropathogens and multidrug resistance detected in urine cultures. This study offers new data on the absolute risk and number needed to harm for individual antibiotic resistance, which can inform shared decision-making discussions on preventing recurrent urinary tract infections (rUTIs).

Probably the first study to establish reference ranges for transient elastography in the third trimester of pregnancy, demonstrating that similar cutoffs can be used to define liver steatosis in this period. By analysing more than 5000 women, we identified maternal and gestational risk factors for steatosis and increased liver stiffness in pregnancy, which include obesity, pre-gestational diabetes, and pre-eclampsia

This study represents the first clinical trial of dichloroacetate, a non-hormonal treatment, for endometriosis-associated pain in 30 women, demonstrating that recruitment and treatment are feasible despite common but manageable side effects. The research directly relates to International Women's Day by addressing endometriosis, a chronic condition affecting an estimated 190 million women worldwide that causes debilitating pelvic pain and infertility, highlighting the urgent need for better treatment options for women's health.

This is the largest cohort study to date of women with hyperemesis gravidarum, and it is the first to explore a wide array of neuropsychiatric and mental health outcomes, including psychotic disorder. Evidence study suggests that while hyperemesis gravidarum increases the risk of poor mental health compared to unaffected pregnancies, the link between its severity and psychiatric burden is complex. The lower depression risk in cases with metabolic disturbance versus mild disease may reflect varying levels of healthcare support.

This study measured testosterone and pre-androgens in blood, finding changes with age but not with menopause. This indicates that menopause itself is not a reason for women to need testosterone supplementation.

Gestational diabetes (GDM) is a lifelong risk factor for type 2 diabetes and cardiovascular disease.This review includes an analysis of 17 studies from high-income countries to map current evidence and identify gaps in care for women with a history of gestational diabetes (GDM).

King’s career illustrates how one woman in mid-twentieth-century America transformed the scope of microbiological work. Her career showed that precise observation and persistence could open paths for women in a field long dominated by men.

This study explores racial inequities in postpartum insurance coverage during the COVID-19 continuous Medicaid coverage period, comparing ACA expansion versus non-expansion states. It concludes that postpartum Medicaid extension improved access but was insufficient to eliminate racial inequities in maternal health coverage.